CATALAYER NEWS
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
Source: BioPharma Dive · 2026-07-28
Full article text is available in the Catalayer news terminal.
RELATED MARKETS
Prediction Markets
Full article text is available in the Catalayer news terminal.